Inicio・Lista de Acciones・Penumbra Inc

Penumbra Inc

Cerrado

SectorSanidad

316.87 -0.53

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

316.87

Máximo

317.89

Métricas clave
By Trading Economics
Ingresos	2.2M 35M
Ventas	15M 390M
P/B Media del Sector	78.783 56.432
BPA	0.88
Margen de beneficios	8.925
Empleados	4,700
EBITDA	5.5M 52M

Recomendaciones
By TipRanks
Recomendaciones	Neutral
Estimación a 12 Meses	+12.85% upside

Dividendos
By Acuity
Próximas Ganancias	4 nov 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	33M 13B
Apertura anterior	317.4
Cierre anterior	316.87

Noticias sobre sentimiento de mercado

By Acuity

50%

115 / 339 Clasificación en Healthcare

Penumbra Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

17 sept 2026, 19:46 UTC

Penumbra Inc is trading slightly lower, remaining roughly flat since Wednesday's close and positioned near the lower end of its one-month range.

16 sept 2026, 22:06 UTC

Penumbra Inc declined in after-market trading, closing lower than Wednesday's close and remaining below the 20-day moving average amid broader market weakness.

28 ago 2026, 19:36 UTC

Penumbra Inc shares are advancing during Friday's session. The stock's performance aligns with ongoing inflation concerns highlighted by recent Fed comments.

27 ago 2026, 21:01 UTC

Penumbra Inc shares are higher in after-market trading. No specific news was identified to explain this movement, though broader market sentiment remains steady.

26 ago 2026, 20:08 UTC

Penumbra Inc's shares are lower today, impacted by a notable decline in the Health Care Equipment sub-sector. No specific news has been identified.

25 ago 2026, 23:01 UTC

Penumbra Inc shares are higher in after-market trading, recovering from earlier declines amid broader market resilience despite fluctuations linked to falling crude oil prices.

24 ago 2026, 23:11 UTC

Penumbra Inc shares are higher in after-market hours, reflecting notable gains since Monday's close and reaching a session high within its one-month trading range.

22 ago 2026, 00:02 UTC

Penumbra Inc shares are higher in after-market hours, rebounding alongside major stocks and remaining above the 20-day moving average. No specific news was identified.

21 ago 2026, 23:31 UTC

Penumbra Inc's shares are higher in after-market trading, rebounding from an initial decline. The stock is above its 20-day moving average.

17 ago 2026, 19:36 UTC

Correlated Moves

Penumbra Inc. shares are lower today, reflecting broader market declines amid rising bond yields and geopolitical tensions. The stock is near its one-month range high.

10 ago 2026, 19:36 UTC

Correlated Moves

Penumbra Inc shares are higher today, supported by positive trends in the health care equipment sector and the performance of related ETFs.

8 ago 2026, 00:02 UTC

Penumbra Inc shares are trading higher in after-market hours, maintaining strength above the 20-day moving average and near the upper end of their one-month range.

7 ago 2026, 19:56 UTC

Penumbra Inc. shares are lower today, despite earlier gains, amid a broader market influenced by a disappointing jobs report and shifting monetary policy sentiment.

6 ago 2026, 19:36 UTC

Penumbra Inc shares are modestly higher today, maintaining an upward trajectory. No specific company news was identified to explain the price movement.

5 ago 2026, 21:03 UTC

Penumbra Inc shares are higher in after-market hours, though no specific news explains the movement. The stock remains above its 20-day moving average.

4 ago 2026, 19:36 UTC

Penumbra Inc shares are higher today, reflecting a slight gain since Monday. The stock remains above its 20-day moving average amid broader market trends.

3 ago 2026, 21:01 UTC

Penumbra Inc. shares are lower in after-market trading, despite gains in the broader market. The decline began shortly after Monday's close.

24 jul 2026, 16:36 UTC

Correlated Moves

Penumbra Inc's shares are higher today, supported by gains in the medical devices sector and a decline in oil prices easing inflation concerns.

Comparación entre iguales

Cambio de precio

Penumbra Inc previsión

Precio Objetivo

By TipRanks

12.85% repunte

Estimación a 12 Meses

Media 358.4 USD 12.85%

Máximo 374 USD

Mínimo 320 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Penumbra Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

6 ratings

Comprar

Mantener

Vender

De acuerdo con 6 analistas que ofrecen calificaciones bursátiles a para Penumbra Inc Dist en los últimos 3 meses.

Sentimiento

By Acuity

115 / 339 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.